⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNXU News
Conexeu Sciences Inc. Common Stock
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
globenewswire.com
IART
VCEL
ORGO
MDXG
CNXU
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
globenewswire.com
CNXU
ORGO
IART
VCEL
MDXG
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
prnewswire.com
SNN
ABBV
CNXU
SYK
ESTA
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
globenewswire.com
CNXU
Form 8-K
sec.gov
CNXU
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
globenewswire.com
CNXU
SNN
IART
MDXG
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
globenewswire.com
CNXU
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
globenewswire.com
CNXU
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
prnewswire.com
IART
ORGO
MDXG
BVS
CNXU
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
globenewswire.com
CNXU